series-a
Stage
2020
Founded
1
Investors
About
Genespire is a clinical-stage biotechnology company developing gene therapies for rare genetic diseases. Its lead program focuses on treating primary immunodeficiencies.
Explore Genespire's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.